REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 787.80
Bid: 787.60
Ask: 788.00
Change: 10.80 (1.39%)
Spread: 0.40 (0.051%)
Open: 776.60
High: 796.60
Low: 773.00
Prev. Close: 777.00
PRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Repurchase to neutralise share scheme issuance

5 Jan 2024 08:35

RNS Number : 7909Y
Prudential PLC
05 January 2024

Prudential plc

Repurchase Programme to neutralise 2023 Employee and Agent share scheme issuance

Prudential plc (the "Company") announces that it will commence a share repurchase programme in respect of c. 3.9 million1 ordinary shares of 5 pence each ("Ordinary Shares"), in the issued share capital of the Company (the "Programme").

The purpose of the Programme is to reduce the issued share capital of the Company to offset dilution from the vesting of awards under employee and agent share schemes during 2023. Based on the total number of Ordinary Shares in issue announced on 29 December 2023, the Programme approximates to 0.14% of the Company's issued share capital. The Directors consider the Programme to be in the best interests of the Company and of its shareholders generally. Given its small size, the implementation of the Programme is expected to marginally enhance earnings per share.

The Company intends to make further repurchases of its Ordinary Shares in future in order to offset the expected dilution from the vesting of awards under employee and agent share schemes. The Company will make further announcements in respect of any such repurchases in due course.

The Company continues to explore means of further focussing issuances of employee and agent share schemes, and enhancing liquidity of the Ordinary Shares held, on the Hong Kong line.

Detailed terms of the Programme

The Company has entered into an irrevocable, non-discretionary arrangement with Barclays Capital Securities Ltd ("Barclays") (acting as riskless principal) to conduct the repurchases in respect of the Programme on its behalf and to make trading decisions in respect of the Programme independently of the Company.

The arrangement with Barclays enables the purchase of Ordinary Shares for a period from 8 January 2024, and will complete no later than 26 January 2024. The aggregate maximum pecuniary amount allocated to the Programme is GBP 38 million (exclusive of associated fees, expenses and stamp duty) (equivalent to HKD 374.7 million, based on the closing exchange rate between GBP and HKD as of 2 January 2024 HKT).

Barclays may effect purchases of Ordinary Shares under the Programme on the London Stock Exchange and/or other trading venues2 for subsequent purchase by the Company. Purchases by the Company will be treated as being made on the London Stock Exchange. The Company intends that any Ordinary Shares purchased will be cancelled.

The Programme is in accordance with the Company's general authority to purchase a maximum of 275,320,612 Ordinary Shares, granted by shareholders at the Company's 2023 Annual General Meeting. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 12 of the UK Listing Rules, the Hong Kong Listing Rules and the Hong Kong Code on Share Buy-backs. No purchase of Ordinary Shares will be conducted on the Hong Kong Stock Exchange. No repurchases will be made in respect of the Company's American Depositary Receipts.

The Company will make further announcements in due course following any repurchase of shares. There is no guarantee that the Programme will be implemented in full or that any shares will be repurchased by the Company.

1 Three million, eight-hundred and fifty-one thousand, three hundred and seventy-six Ordinary Shares (3,851,376)

2 Being any multilateral trading facility operated by Turquoise Services Limited, Aquis Limited, Cboe Europe Limited and CBOE BXE

Additional information

About Prudential plc

Prudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

https://www.prudentialplc.com/

Contact

Media

Investors/Analysts

Simon Kutner

+44 (0)7581 023260

Patrick Bowes

+852 9611 2981

Sonia Tsang

+852 5580 7525

William Elderkin

+44 (0)20 3977 9215

Sophie Sophaon

+852 6286 0229

Darwin Lam

+852 2918 6348

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSBAMPTMTJMMII
Date   Source Headline
3rd Oct 202310:29 amRNSOverseas Regulatory Announcement-Grant of Options
29th Sep 20239:41 amRNSTotal Voting Rights
26th Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Sep 202310:25 amRNS2023 Half-year Report
13th Sep 20239:59 amRNSDirector/PDMR Shareholding
31st Aug 20239:39 amRNSTotal Voting Rights
30th Aug 20237:02 amRNSDividend Declaration
30th Aug 20237:00 amRNSPrudential plc – HY23 Results – Risk Factors
30th Aug 20237:00 amRNSPrudential plc – HY23 Results – Additional Info
30th Aug 20237:00 amRNSPrudential plc – HY23 Results – EEV
30th Aug 20237:00 amRNSPrudential plc – HY23 Results – IFRS
30th Aug 20237:00 amRNSPrudential plc – HY17 Results – Business Review
14th Aug 20239:45 amRNSDirector/PDMR Shareholding
31st Jul 202310:21 amRNSTotal Voting Rights
25th Jul 20239:39 amRNSDirector Declaration
20th Jul 202310:05 amRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSPrudential Plc - IFRS17 Briefing
17th Jul 20239:46 amRNSDirector/PDMR Shareholding
12th Jul 202311:46 amRNSDirector/PDMR Shareholding
30th Jun 202310:08 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Jun 20239:55 amRNSTotal Voting Rights
13th Jun 20234:24 pmRNSDirector/PDMR Shareholding
13th Jun 20234:20 pmRNSDirector/PDMR Shareholding
6th Jun 20239:33 amRNSPublication of a Prospectus
2nd Jun 202310:48 amRNSOverseas Regulatory Announcement - Grant of Awards
2nd Jun 202310:46 amRNSDirector/PDMR Shareholding
2nd Jun 202310:40 amRNSOverseas Regulatory Announcement - Grant of Awards
31st May 20232:58 pmRNSBlock listing six monthly return
31st May 20239:39 amRNSTotal Voting Rights
31st May 20237:00 amRNSPrudential appoints Ben Bulmer as CFO
26th May 20232:59 pmRNSDirector/PDMR Shareholding
25th May 20232:04 pmRNSDirectorate Change
25th May 20232:00 pmRNSResult of AGM
23rd May 202312:23 pmRNSDirector/PDMR Shareholding
22nd May 20233:06 pmRNSOverseas Regulatory Announcement - Grant of Awards
16th May 202310:44 amRNSDirector/PDMR Shareholding
16th May 202310:38 amRNSDirector/PDMR Shareholding
12th May 202312:33 pmRNSDirector/PDMR Shareholding
12th May 202312:26 pmRNSDirector/PDMR Shareholding
28th Apr 20239:47 amRNSTotal Voting Rights
28th Apr 20237:00 amRNSPrudential Plc - Business Performance Update
27th Apr 20239:53 amRNSDividend Rate Achieved
21st Apr 20239:44 amRNSNotice of AGM
13th Apr 202312:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20239:30 amRNSDirector/PDMR Shareholding
31st Mar 20232:04 pmRNSTotal Voting Rights
28th Mar 20239:50 amRNSDirector/PDMR Shareholding
23rd Mar 20232:26 pmRNSAnnual Report and Account 2022 and Form 20-F
23rd Mar 202311:00 amRNSBlock Listing Application
22nd Mar 202311:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.